Ted R Miller1,2, David I Swedler1, Bruce A Lawrence1, Bina Ali1, Ian R H Rockett3, Nancy N Carlson4, Jennifer Leonardo5. 1. Pacific Institute for Research and Evaluation, Calverton, Maryland. 2. Curtin University School of Public Health, Perth, Australia. 3. School of Public Health, West Virginia University, Morgantown, West Virginia. 4. American Counseling Association, Alexandria, Virginia. 5. Education Development Center, Waltham, Massachusetts.
Abstract
Importance: Prior lethality analyses of suicide means have historically treated drug poisoning other than alcohol poisoning as a lumped category. Assessing risk by drug class permits better assessment of prevention opportunities. Objective: To investigate the epidemiology of drug poisoning suicides. Design, Setting, and Participants: This cross-sectional study analyzed censuses of live emergency department and inpatient discharges for 11 US states from January 1, 2011, to December 31, 2012, as well as Healthcare Cost and Utilization Project national live discharge samples for January 1 to December 31, 2012, and January 1 to December 31, 2016, and corresponding Multiple Cause of Death census data. Censuses or national samples of all medically identified drug poisonings that were deliberately self-inflicted or of undetermined intent were identified using diagnosis and external cause codes. Data were analyzed from June 2019 to January 2020. Main Outcomes and Measures: Distribution of drug classes involved in suicidal overdoses. Logistic regressions on the state data were used to calculate the odds and relative risk (RR) of death for a suicide act that involved a drug class vs similar acts excluding that class. Results: Among 421 466 drug poisoning suicidal acts resulting in 21 594 deaths, 19.6% to 22.5% of the suicidal drug overdoses involved benzodiazepines, and 15.4% to 17.3% involved opioids (46.2% men, 53.8% women, and <0.01% missing; mean age, 36.4 years). Opioids were most commonly identified in fatal suicide poisonings (33.3%-47.8%). The greatest RR for poisoning suicide completion was opioids (5.20 times the mean for suicide acts that did not involve opioids; 95% CI, 4.86-5.57; sensitivity analysis range, 3.99-6.86), followed by barbiturates (RR, 4.29; 95% CI, 3.35-5.45), antidepressants (RR, 3.22; 95% CI, 2.95-3.52), antidiabetics (RR, 2.57; 95% CI, 1.94-3.41), and alcohol (conservatively, because 30% of death certifiers do not test for alcohol; RR, 2.04; 95% CI, 1.84-2.26). The updated toxin diagnosis coding in International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, used to code the 2016 data revealed that calcium channel blockers also had a high RR of 2.24 (95% CI, 1.89-2.61). Translated to attributable fractions, approximately 81% of suicides involving opioids would not have been fatal absent opioids. Similarly, 34% of alcohol-involved suicide deaths were alcohol attributable. Conclusions and Relevance: These findings suggest that preventing access to lethal means for patients at risk for suicide should extend to drugs with high case fatality rates. Blister packing and securely storing lethal drugs seems advisable.
Importance: Prior lethality analyses of suicide means have historically treated drug poisoning other than alcoholpoisoning as a lumped category. Assessing risk by drug class permits better assessment of prevention opportunities. Objective: To investigate the epidemiology of drug poisoning suicides. Design, Setting, and Participants: This cross-sectional study analyzed censuses of live emergency department and inpatient discharges for 11 US states from January 1, 2011, to December 31, 2012, as well as Healthcare Cost and Utilization Project national live discharge samples for January 1 to December 31, 2012, and January 1 to December 31, 2016, and corresponding Multiple Cause of Death census data. Censuses or national samples of all medically identified drug poisonings that were deliberately self-inflicted or of undetermined intent were identified using diagnosis and external cause codes. Data were analyzed from June 2019 to January 2020. Main Outcomes and Measures: Distribution of drug classes involved in suicidal overdoses. Logistic regressions on the state data were used to calculate the odds and relative risk (RR) of death for a suicide act that involved a drug class vs similar acts excluding that class. Results: Among 421 466 drug poisoning suicidal acts resulting in 21 594 deaths, 19.6% to 22.5% of the suicidal drug overdoses involved benzodiazepines, and 15.4% to 17.3% involved opioids (46.2% men, 53.8% women, and <0.01% missing; mean age, 36.4 years). Opioids were most commonly identified in fatal suicide poisonings (33.3%-47.8%). The greatest RR for poisoning suicide completion was opioids (5.20 times the mean for suicide acts that did not involve opioids; 95% CI, 4.86-5.57; sensitivity analysis range, 3.99-6.86), followed by barbiturates (RR, 4.29; 95% CI, 3.35-5.45), antidepressants (RR, 3.22; 95% CI, 2.95-3.52), antidiabetics (RR, 2.57; 95% CI, 1.94-3.41), and alcohol (conservatively, because 30% of death certifiers do not test for alcohol; RR, 2.04; 95% CI, 1.84-2.26). The updated toxin diagnosis coding in International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, used to code the 2016 data revealed that calcium channel blockers also had a high RR of 2.24 (95% CI, 1.89-2.61). Translated to attributable fractions, approximately 81% of suicides involving opioids would not have been fatal absent opioids. Similarly, 34% of alcohol-involved suicide deaths were alcohol attributable. Conclusions and Relevance: These findings suggest that preventing access to lethal means for patients at risk for suicide should extend to drugs with high case fatality rates. Blister packing and securely storing lethal drugs seems advisable.
Authors: Chongliang Luo; Kun Chen; Riddhi Doshi; Nathaniel Rickles; Yong Chen; Harold Schwartz; Robert H Aseltine Journal: PLoS One Date: 2022-06-30 Impact factor: 3.752
Authors: Eva M Peñas-Lledó; Sebastien Guillaume; Fernando de Andrés; Ana Cortés-Martínez; Jonathan Dubois; Jean Pierre Kahn; Marion Leboyer; Emilie Olié; Adrián LLerena; Philippe Courtet Journal: Transl Psychiatry Date: 2022-10-18 Impact factor: 7.989
Authors: Lily A Brown; Cecile M Denis; Anthony Leon; Michael B Blank; Steven D Douglas; Knashawn H Morales; Paul F Crits-Christoph; David S Metzger; Dwight L Evans Journal: Drug Alcohol Depend Date: 2021-04-24 Impact factor: 4.852
Authors: Cecile M Denis; Tiffany Dominique; Peter Smith; Danielle Fiore; Yi-Chien Ku; Angus Culhane; Debora Dunbar; Dana Brown; Menvekeh Daramay; Chelsea Voytek; Knashawn H Morales; Michael B Blank; Paul F Crits-Christoph; Steven D Douglas; Serguei Spitsin; Ian Frank; Krystal Colon-Rivera; Luis J Montaner; David S Metzger; Dwight L Evans Journal: AIDS Behav Date: 2021-01-15
Authors: In Young Choi; Sun-Young Kim; Jhin Goo Chang; Hoo Rim Song; Woo Jung Kim; Su Young Lee; Hyun-Soo Kim; Minha Hong Journal: Soa Chongsonyon Chongsin Uihak Date: 2021-01-01